MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Funding Opportunities: Pioneers, Architects & Consolidators
Funding: U.S. Federal
*Funding: HHS
*HHS: Contracts, Contractors & Awards
*BARDA: Contracts (IDIQ, GWACS, Etc.), Contractors & Awardees
*Contractors & Awardees: BARDA
Access to Advanced Health Institute (AAHI), formerly, Infectious Disease Research Institute (IDRI)
Organization & Developments: AAHI, formerly IDRI
Parents
Access to Advanced Health Institute (AAHI), formerly, Infectious Disease Research Institute (IDRI)
Children
*AAHI is a nonprofit biotech research institute located in Seattle, Washington that combines the high-quality science of an academic research organization with the product-development capabilities of a biotech company to help combat some of the world’s deadliest diseases, including COVID-19, cancer, fungal and parasitic infections, and other non-communicable diseases
*For nearly three decades, AAHI and its predecessor, IDRI, have focused on creating immune-enhancing technologies that improve the body’s natural response to disease.
2011: Infectious Disease Research Institute Receives Grant for TB Drug Research (2011)
2014: Gates Foundation Awards $3.4 Million for TB Drug Research
2015: Sanofi, Gates Foundation and IDRI team up to improve vaccine development process
2018: NIAID_Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
2019: Infectious Disease Research Institute Cuts Staff, Programs
2019: NIH awards contracts to advance tuberculosis immunology research
2019: Research Nonprofit Shutters TB Vaccine Effort and Lays Off Scientists_ www.nytimes.com
2022: Access to Advanced Health Institute receives $26 million gift
2022: Announcement of Upcoming Launch of Access to Advanced Health Institute and The Africa’s Access to Advanced Healthcare (AAAH) Coalition
2022: Infectious Disease Research Institute Exits Receivership and Launches AAHI, the Access to Advanced Health Institute, with $50 Million Funding Commitment
2022: Released from court oversight, a Seattle research institution rebrands and resets – GeekWire
2022: The Access to Advanced Health Institute Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate that is Stable at Room Temperature
2023: Temperature-Stable TB Vaccine Safe, Prompts Immune Response in NIH-Supported Study
Jumps
*Key People: AAHI, formerly IDRI
Finance & Acquisitions: AAHI, formerly IDRI